BioTech Annecto

biotechannecto.com

BioTech Annecto is a social networking organization, whose aim is to bring together entrepreneurs, investors, scientists, attorneys, journalists and other professionals in the biotechnology sector: pharmaceutical, healthcare and biomedical, cosmetics, and environment. Launched February 2009 in Montreal (Quebec, Canada), BioTech Annecto (previously known as BioTech Montreal) is inviting people, one Tuesday every month, from the Montreal biotechnology community to meet at trendy locations around town. Members come from the business world, from public agencies as well as academic institutions. This allows regular communication and exchanges between industry, the public sector and academia.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Industrial Impact

AANIKA BIOSCIENCES FIRST BIOTECH COMPANY TO RECEIVE BERMUDA MONETARY AUTHORITY’S APPROVAL FOR REINSURANCE INNOVATION HUB

Aanika Biosciences, | February 25, 2022

news image

Aanika Biosciences, an emerging biotech company using microbial based technologies to protect the safety and security of our food system, announced today it has received acceptance into the Bermuda Monetary Authority’s (BMA) Innovation Hub. The program will allow reinsurers to explore how the application of Aanika’s traceability and prevention technology can help reduce the magnitude and size of claims while lowering premiums and expanding protection for the food and agriculture indu...

Read More

SAIBA AG SELECTS AGC BIOLOGICS TO DEVELOP AND PRODUCE COVID-19 VACCINE

AGC Biologics | June 16, 2020

news image

AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), has announced it will be partnering with Saiba AG to manufacture a SARS-CoV-2 vaccine to protect against COVID-19. Saiba AG is a Swiss biotechnology company that specializes in the research and development of virus-like particle (VLP) vaccines for infectious and chronic diseases. Saiba AG is leveraging its patented Cucumber Mosaic Virus VLP platform technology to develop the SARS-CoV-2 vaccine. ...

Read More

Industrial Impact

CHIMERON BIO EXPANDS FOOTPRINT IN PHILADELPHIA BY JOINING BIOLABS AT THE CURTIS

Chimeron Bio | January 25, 2022

news image

Chimeron Bio, a biotechnology company pioneering a novel class of self-amplifying RNA-vaccines and therapeutics announced its plan to expand operations in the Philadelphia area and move to The Curtis, a landmark site in Center City Philadelphia under BioLabs, the leading developer and operator of life science co-working spaces in the U.S. and internationally. The move stems from Chimeron’s need for an expanded footprint to accommodate its growing R&D team and operations....

Read More

Medical

OCHRE BIO LAUNCHES ‘LIVER ICU’ IN THE UNITED STATES TO EVALUATE EFFECTS OF RNA THERAPIES ON HUMAN LIVER PERFORMANCE

Ochre Bio | May 12, 2022

news image

Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases, announced today the launch of their ‘Liver ICU’. Housed in BioLabs@NYULangone, a biopharma incubator in New York City, this research site will evaluate the efficacy of new RNA therapeutics on whole human livers maintained on machines. The use of discarded donor livers for research is expected to enhance timelines and accuracy of liver medicine research by testing interventions directly in human livers m...

Read More
news image

Industrial Impact

AANIKA BIOSCIENCES FIRST BIOTECH COMPANY TO RECEIVE BERMUDA MONETARY AUTHORITY’S APPROVAL FOR REINSURANCE INNOVATION HUB

Aanika Biosciences, | February 25, 2022

Aanika Biosciences, an emerging biotech company using microbial based technologies to protect the safety and security of our food system, announced today it has received acceptance into the Bermuda Monetary Authority’s (BMA) Innovation Hub. The program will allow reinsurers to explore how the application of Aanika’s traceability and prevention technology can help reduce the magnitude and size of claims while lowering premiums and expanding protection for the food and agriculture indu...

Read More
news image

SAIBA AG SELECTS AGC BIOLOGICS TO DEVELOP AND PRODUCE COVID-19 VACCINE

AGC Biologics | June 16, 2020

AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), has announced it will be partnering with Saiba AG to manufacture a SARS-CoV-2 vaccine to protect against COVID-19. Saiba AG is a Swiss biotechnology company that specializes in the research and development of virus-like particle (VLP) vaccines for infectious and chronic diseases. Saiba AG is leveraging its patented Cucumber Mosaic Virus VLP platform technology to develop the SARS-CoV-2 vaccine. ...

Read More
news image

Industrial Impact

CHIMERON BIO EXPANDS FOOTPRINT IN PHILADELPHIA BY JOINING BIOLABS AT THE CURTIS

Chimeron Bio | January 25, 2022

Chimeron Bio, a biotechnology company pioneering a novel class of self-amplifying RNA-vaccines and therapeutics announced its plan to expand operations in the Philadelphia area and move to The Curtis, a landmark site in Center City Philadelphia under BioLabs, the leading developer and operator of life science co-working spaces in the U.S. and internationally. The move stems from Chimeron’s need for an expanded footprint to accommodate its growing R&D team and operations....

Read More
news image

Medical

OCHRE BIO LAUNCHES ‘LIVER ICU’ IN THE UNITED STATES TO EVALUATE EFFECTS OF RNA THERAPIES ON HUMAN LIVER PERFORMANCE

Ochre Bio | May 12, 2022

Ochre Bio, a biotech company developing RNA medicines for chronic liver diseases, announced today the launch of their ‘Liver ICU’. Housed in BioLabs@NYULangone, a biopharma incubator in New York City, this research site will evaluate the efficacy of new RNA therapeutics on whole human livers maintained on machines. The use of discarded donor livers for research is expected to enhance timelines and accuracy of liver medicine research by testing interventions directly in human livers m...

Read More